BioForward Member News

13May 2020

Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all […]

12May 2020

Read the full story from Healthcare Finance here. The Federal Communications Commission today granted GE Healthcare’s request for a waiver to allow the importation, marketing and operation of certain GE medical devices from new suppliers for use in healthcare facilities. The order, which was issued by the Wireless Telecommunications Bureau and Office of Engineering and […]

11May 2020

Read the full press release from SHINE Medical Technologies here. SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it […]

11May 2020

Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company’s commercial […]

10May 2020

Read the full story from the Wisconsin State Journal here. A Madison-based diagnostics company wants to make testing for the COVID-19 coronavirus easier and quicker for patients and health care providers. GoDx has been developing paper-based tests for pathogens that cause gastrointestinal diseases, such as salmonella and norovirus. While those tests are currently undergoing clinical […]

07May 2020

Read the full story from WISCONSININNO. Madison-based Nimble Therapeutics, a fairly new company that was spun out from Switzerland-based F. Hoffmann-La Roche, is collaborating with Roche Diagnostics to discover and develop novel peptide-based molecules for diagnostics of SARS-CoV-2, the virus that causes COVID-19. Nimble Therapeutics is developing a chemical synthesis technology for drug development. The […]

04May 2020

Read the full press release from BioSpace here. Arcturus Therapeutics, Inc. Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health […]

04May 2020

Read the full story from BizTimes here. A potential single shot COVID-19 vaccine will be produced at Catalent, Inc.’s biomanufacturing facility in Madison. Somerset, New Jersey-based Catalent and San Diego-based Arcturus Therapeutics Holdings Inc. announced Monday they are partnering to manufacture a COVID-19 mRNA vaccine candidate. The LUNAR-COV19 vaccine will be produced at Catalent Biologics’ […]